180 related articles for article (PubMed ID: 24718755)
1. Audiovestibular Characteristics of Small Cochleovestibular Schwannomas in Neurofibromatosis Type 2.
Holliday MA; Kim HJ; Zalewski CK; Wafa T; Dewan R; King KA; Brewer CC; Butman JA; Asthagiri AR
Otolaryngol Head Neck Surg; 2014 Jul; 151(1):117-24. PubMed ID: 24718755
[TBL] [Abstract][Full Text] [Related]
2. Audiologic Natural History of Small Volume Cochleovestibular Schwannomas in Neurofibromatosis Type 2.
deTorres AT; Brewer CC; Zalewski CK; King KA; Walker R; Scott GC; Asthagiri AR; Chittiboina P; Kim HJ
Otol Neurotol; 2018 Mar; 39(3):357-364. PubMed ID: 29342057
[TBL] [Abstract][Full Text] [Related]
3. Role of cervical vestibular evoked myogenic potentials (cVEMP) and auditory brainstem response (ABR) in the evaluation of vestibular schwannoma.
Valame DA; Gore GB
Braz J Otorhinolaryngol; 2017; 83(3):324-329. PubMed ID: 27174775
[TBL] [Abstract][Full Text] [Related]
4. Cervical vestibular-evoked myogenic potential in vestibular schwannoma after gamma-knife surgery.
Lee YF; Lee CC; Wang MC; Liu KD; Wu HM; Guo WY; Shiao AS; Pan DH; Chung WY; Hsu SP
Auris Nasus Larynx; 2015 Aug; 42(4):265-70. PubMed ID: 25666552
[TBL] [Abstract][Full Text] [Related]
5. Vestibular evoked myogenic potentials in neurofibromatosis 2.
Wang CP; Hsu WC; Young YH
Ann Otol Rhinol Laryngol; 2005 Jan; 114(1 Pt 1):69-73. PubMed ID: 15697166
[TBL] [Abstract][Full Text] [Related]
6. Audiovestibular Loss of Function Correlates in Vestibular Schwannomas.
West N; Møller MN; Hansen S; Cayé-Thomasen P
J Int Adv Otol; 2018 Aug; 14(2):161-165. PubMed ID: 30100546
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Differences in Intracranial Facial Versus Vestibular Schwannomas: A Four Nerve Assessment.
Erbele ID; Klumpp ML; Arriaga MA
Laryngoscope; 2021 Sep; 131(9):2098-2105. PubMed ID: 34013983
[TBL] [Abstract][Full Text] [Related]
8. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
9. Correlating vestibular schwannoma size with vestibular-evoked myogenic potential results.
Lin KL; Chen CM; Wang SJ; Young YH
Ear Hear; 2014; 35(5):571-6. PubMed ID: 24846629
[TBL] [Abstract][Full Text] [Related]
10. Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.
Bonne N-; Aboukais R; Baroncini M; Hochart A; Leblond P; Broly F; Dubrulle F; Lejeune JP; Vincent C
Childs Nerv Syst; 2016 Dec; 32(12):2403-2413. PubMed ID: 27704245
[TBL] [Abstract][Full Text] [Related]
11. [The significance of electrophysiologic examinations in vestibular schwannomas diagnosis].
Pierchała K; Morawski K; Lukawska I; Niemczyk K
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):60-6. PubMed ID: 22000252
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Magnetic Resonance Imaging Diagnostic Approaches for Vestibular Schwannoma Based on Hearing Threshold Differences Between Ears: Added Value of Auditory Brainstem Responses.
Metselaar M; Demirtas G; van Immerzeel T; van der Schroeff M
Otol Neurotol; 2015 Dec; 36(10):1610-5. PubMed ID: 26485589
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
15. Correlating the cochleovestibular deficits with tumor size of acoustic neuroma.
Day AS; Wang CT; Chen CN; Young YH
Acta Otolaryngol; 2008 Jul; 128(7):756-60. PubMed ID: 18568517
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of hearing loss in neurofibromatosis type 2.
Asthagiri AR; Vasquez RA; Butman JA; Wu T; Morgan K; Brewer CC; King K; Zalewski C; Kim HJ; Lonser RR
PLoS One; 2012; 7(9):e46132. PubMed ID: 23049959
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
[TBL] [Abstract][Full Text] [Related]
18. Audiologic presentation of vestibular schwannomas in neurofibromatosis type 2.
Lalwani AK; Abaza MM; Makariou EV; Armstrong M
Am J Otol; 1998 May; 19(3):352-7. PubMed ID: 9596188
[TBL] [Abstract][Full Text] [Related]
19. Auditory brainstem response threshold differences in patients with vestibular schwannoma: a new diagnostic index.
Bush ML; Jones RO; Shinn JB
Ear Nose Throat J; 2008 Aug; 87(8):458-62. PubMed ID: 18712694
[TBL] [Abstract][Full Text] [Related]
20. Video Head Impulse Test Results in Patients With a Vestibular Schwannoma-Sensitivity and Correlation With Other Vestibular System Function Tests, Hearing Acuity, and Tumor Size.
West N; Sass H; Klokker M; Cayé-Thomasen P
Otol Neurotol; 2020 Jun; 41(5):e623-e629. PubMed ID: 32118807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
